Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stehle

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Anti-Cancer Drugs|June 23, 1999
Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing ratsG Stehle, A Wunder, H H Schrenk, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Anti-factor Xa determination in blood: a new method for controlling heparin therapyJ Harenberg, B Haaf, M Schäfer, et al.
Anti-Cancer Drugs|November 26, 1999
Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugateG Stehle, A Wunder, H H Schrenk, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparinJ Harenberg, B Weuster, M Pfitzer, et al.
Thrombosis and Haemostasis|August 1, 1995
Comparison of immunological and functional assays for measurement of soluble fibrinC E Dempfle, S A Pfitzner, M Dollman, et al.
Lancet (London, England)|October 27, 1990
Cardiogenic shock associated with verapamil in a patient with liver cirrhosisG Stehle, J Buss, J Eibach, et al.
Klinische Wochenschrift|March 18, 1991
Incidence and mortality rates of myocardial infarction in Chinese workers aged 40-59 in relation to coronary risk factors. Results of a Chinese prospective study (Wuhan Study) in comparison to the Göttingen Risk Incidence and Prevalence Study (GRIPS)R Bernhardt, Z Feng, Y Deng, et al.
Anti-Cancer Drugs|August 1, 1997
The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in ratsG Stehle, H Sinn, A Wunder, et al.
International Journal of Cancer|June 17, 1998
Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinomaA Wunder, G Stehle, H H Schrenk, et al.
Seminars in Perinatology|April 3, 2023
Evaluating the evidence behind umbilical cord clamping practices in at-risk neonatal populationsChelsea K Bitler, Brian K Rivera, Srikruthi Godavarthi, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drugs|June 23, 1999
Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing ratsG Stehle, A Wunder, H H Schrenk, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Anti-factor Xa determination in blood: a new method for controlling heparin therapyJ Harenberg, B Haaf, M Schäfer, et al.
Anti-Cancer Drugs|November 26, 1999
Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugateG Stehle, A Wunder, H H Schrenk, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparinJ Harenberg, B Weuster, M Pfitzer, et al.
Thrombosis and Haemostasis|August 1, 1995
Comparison of immunological and functional assays for measurement of soluble fibrinC E Dempfle, S A Pfitzner, M Dollman, et al.
Lancet (London, England)|October 27, 1990
Cardiogenic shock associated with verapamil in a patient with liver cirrhosisG Stehle, J Buss, J Eibach, et al.
Klinische Wochenschrift|March 18, 1991
Incidence and mortality rates of myocardial infarction in Chinese workers aged 40-59 in relation to coronary risk factors. Results of a Chinese prospective study (Wuhan Study) in comparison to the Göttingen Risk Incidence and Prevalence Study (GRIPS)R Bernhardt, Z Feng, Y Deng, et al.
Anti-Cancer Drugs|August 1, 1997
The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in ratsG Stehle, H Sinn, A Wunder, et al.
International Journal of Cancer|June 17, 1998
Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinomaA Wunder, G Stehle, H H Schrenk, et al.
Seminars in Perinatology|April 3, 2023
Evaluating the evidence behind umbilical cord clamping practices in at-risk neonatal populationsChelsea K Bitler, Brian K Rivera, Srikruthi Godavarthi, et al.
Pageof 6